National Comprehensive Cancer Network

Subscriptions & Products
For Patients

About NCCN

Central Nervous System Cancers Panel - Disclosures as of 9/2/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Philip J. Bierman, MD

Bradmer Pharmaceuticals

None

None

None

9/18/2009

Henry Brem, MD

None

None

None

None

11/5/2009

Steven Brem, MD

None

Eisai, Inc.

None

None

1/4/2010

Nicholas Butowski, MD

None

None

None

None

9/11/2009

Marc C. Chamberlain, MD

NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas

Enzon Pharmaceuticals;
Exelixis Inc.;
Genentech, Inc.;
Schering-Plough Corporation

None

None

4/13/2010

E. Antonio Chiocca, MD, PhD

None

None

None

None

11/23/2009

Lisa M. DeAngelis, MD

None

Genentech, Inc.

None

None

12/4/2009

Robert A. Fenstermaker, MD

None

None

None

None

11/13/2009

Allan Friedman, MD

None

None

None

None

1/4/2010

Lauren Gallagher, RPh, PhD

None

None

None

None

8/23/2010

Mark R Gilbert, MD

RTOG Trial

Genentech, Inc.;
Pfizer Inc.;
Schering-Plough Corporation

None

None

12/2/2009

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

8/30/2010

Deneen Hesser, MSHSA, RN, OCN

None

None

None

Genentech, Inc.;
Takeda Pharmaceuticals North America, Inc.

11/10/2009

Maria Ho, PhD

None

None

None

None

7/15/2010

Larry Junck, MD

Genentech, Inc.

Genentech, Inc.

None

None

11/16/2009

Gerald P. Linette, MD, PhD

None

None

None

None

9/28/2009

Jay S. Loeffler, MD

None

Genentech, Inc.;
ProCure;
TransMolecular

None

None

7/21/2009

Moshe H Maor, MD

None

None

None

None

8/4/2009

Joan S. McClure, MS

None

None

None

None

7/18/2010

Nicole McMillian, MS

None

None

None

None

7/15/2010

Madison Michael, MD

       

Pending

Paul L. Moots, MD

ECOG;
EMD Sereno

None

None

None

11/16/2009

Tara Morrison, MD, FRCPC

None

Genentech, Inc.

None

None

9/25/2009

Maciej M. Mrugala, MD, PhD, MPH

None

Enzon Pharmaceuticals;
Schering-Plough Corporation

None

None

11/24/2009

Louis Burt Nabors, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Merck KGaA;
Transmolecular

Merck KGaA

None

None

4/27/2010

Herbert B. Newton, MD

None

Eisai Inc.;
UCB Pharma;
Schering-Plough Corporation

None

None

9/28/2009

Jana Portnow, MD

None

None

None

None

9/24/2009

Jeffrey J. Raizer, MD

Eli Lilly and Company;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Vion

Enzon Pharmaceuticals;
Genentech, Inc.;
Schering-Plough Corporation

None

None

11/30/2009

Lawrence Recht, MD

Genentech, Inc.;
Celtic Pharmaceuticals;
Schering-Plough Corporation

Genentech, Inc.

None

None

12/9/2009

Dennis C. Shrieve, MD, PhD

None

None

None

None

9/28/2009

Allen K. Sills, MD

None

None

None

None

11/24/2009

Frank D. Vrionis, MD, MPH, PhD

Synthes Stryker

Medtronic, Inc.;
Florida Board of Medicine;
Orthopix;
Southeastern Brain Tumor Association

None

None

4/21/2010

Patrick Yung Wen, MD

None

Genentech, Inc.

None

None

7/7/2010

 

NCCN Website Supporters